Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction

Published:2023-05 Issue:19 Volume:81 Page:1918-1932
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kanji Rahim,Gue Ying X.,Memtsas Vassilios,Spencer Neil H.,Gorog Diana A.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: subgroup analysis of the ELISA-3 trial;Badings;Catheter Cardiovasc Interv,2016

2. Clinical and angiographic characteristics of patients with spontaneous reperfusion in ST-segment elevation myocardial infarction;Wang;Medicine (Baltimore),2020

3. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials);Brener;Am J Cardiol,2011

4. Outcomes of patients presenting with clinical indices of spontaneous reperfusion in ST-elevation acute coronary syndrome undergoing deferred angiography;Fefer;J Am Heart Assoc,2017

5. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials;Stone;Circulation,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters;European Heart Journal;2024-05-28

2. Spontaneous reperfusion in STEMI: Its mechanisms and possible modulation;Polish Heart Journal;2024-04-30

3. Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome: The VaLiDate-R study;Thrombosis Research;2024-04

4. Platelet reactivity and activated clotting time predict hemorrhagic site complications in patients with chronic coronary syndromes undergoing percutaneous coronary interventions;Coronary Artery Disease;2024-01-22

5. Thrombotic Coronary Occlusion and Reperfusion;Journal of the American College of Cardiology;2023-05